Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites

Journal of General Virology

Volumn 77, Issue 2, 1996, Pages 339-346

  Lafay, Florence ^a   Benmansour, Abdenour ^a,b   Chebli, Karim ^a   Flamand, Anne ^a  

^a CNRS   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; IMMUNOBLOTTING; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RABIES VIRUS; VIRUS NEUTRALIZATION; YEAST;

RABIES VIRUS;

EID: 0030066869     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-2-339     Document Type: Article

References (24)

1. BENICHOU, S., LEGRAND, R., NAKAGAWA, N., FAURE, T., TRAINCARD, F., VOGT, G., DORMONT, D., TIOLLAIS, P., KIENY, M. P. & MADAULE, P. (1992). Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Research and Human Retroviruses 8, 1165-1170
2. BENMANSOUR, A., LEBLOIS, H., COULON, P., TUFFERAU, C., GAUDIN, Y., FLAMAND, A. & LAFAY, F. (1991). Antigenicity of rabies glycoprotein. Journal of Virology 65, 4198-4203.
3. BENMANSOUR, A., BRAHIMI, M., TUFFEREAU, C., COULON, P., LAFAY, F. & FLAMAND, A. (1992). Rapid sequence evolution of street rabies glycoprotein is related to the highly heterogeneous nature of viral population. Virology 187, 33-45.
4. BRAKE, A. J., MERRY-WEATHER, J. P., COIT, D. G., HEBERLEIN, U. A., MASIARZ, F. R., MULLENBACH, G. T., URDEA, M. S., VALENZUELA, P. & BARR, P. J. (1984). α-Factor directed synthesis and secretion of mature foreign proteins in S. cerevisiae. Proceedings of the National Academy of Sciences, USA 82, 7086-7090.
5. BUNSCHOTEN, H., GORE, M., CLAASSEN, I. J. T. M., UYTDEHAAG, F. G. C. M., DIETZSCHOLD, B., WUNNER, W. H. & OSTERHAUS, A. D. M. E (1989). Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. Journal of General Virology 70, 291-298.
6. DIETZSCHOLD, B., GORE, M . CASALI, P., UEKI, Y., RUPPRECHT, C. E., NOTKINS, A. L. & KOPROWSKI, H. (1990a). Biological characterization of human monoclonal antibodies to rabies virus. Journal of Virology 64, 3087-3090.
7. DIETZSCHOLD, B , GORE, M., MARCHADIER, D , NIU, H S., BUNSCHOTEN, H. M . ÖTVÖS. L., JR, WUNNER, W H., ERTL, H. C. J., OSTERHAUS, A D. M. E. & KOPROWSKI, H. (1990b) Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies glycoprotein and its possible use in a synthetic vaccine. Journal of Virology 64, 3804-3809.
8. ITO, H., SUKADA, Y., MUREATA, K. & KIMURA, A. (1983). Transformation of intact yeast cells treated with alkali cations. Journal of Bacteriology 153, 163-168.
9. KLEPPER, S. R., DEBOUCK, C , UFFELMAN, J., JACOBS, P., BOLLEN, A. & JONES, E. V. (1993). Characterization of rabies glycoprotein expressed in yeast. Archives of Virology 128, 269-286.
10. LAFON, M., WIKTOR, T. & MACFARLAN, R. I. (1983). Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. Journal of General Virology 64, 843-851.
11. MADAULE, P., GAIRIN, J. E., BENICHOU, S. & ROSSIER, J. (1991). A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1. FEMS Microbiology and Immunology 76, 99-108.
12. MINK, M. A., BENICHOU, S., MADAULE, P., TIOLLAIS, P., PRINCE, A. M. & INCHAUSPE, G. (1994). Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 200, 246-255
13. MIYAJIMA, A., BOND, M. W., OTSU, K., ARAI, K. & ARAI, N. (1985). Secretion of mature mouse interleukin-2 by Saccharomyces cerevisiae: use of a general secretion vector containing promoter and leader sequences of the mating pheromone α-factor. Gene 37, 155-161.
14. MULLER, G. M., SHAPIRA, M. & ARNON, R. (1982). Anti-influenza response achieved by immunization with synthetic conjugate. Proceedings of the National Academy of Sciences, USA 79, 569-573.
15. NORAZ, N., BENICHOU, S., MADAULE, P., TIOLLAIS, P., VERNANT, J. C. & DESGRANGES, C. (1993). Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains. Virology 193, 80-88.
16. PARRY, N. R., BARNETT, P. V., OULDRIDGE, E J., ROWLANDS, D. J. & BROWN, F. (1989). Neutralizing epitopes of type O foot-and-mouth disease virus. II Mapping three conformational sites with synthetic peptide reagents. Journal of General Virology 70, 1493-1503.
17. PARRY, N , FOX, G., ROWLANDS, D., BROWN, F., FRY, E., ACHARYA, R., LOGAN, D. & STUART, D. (1990). Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347, 569-572.
18. PRÉHAUD, C., COULON, P., LAFAY, F., THIERS, C. & FLAMAND, A. (1988). Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. Journal of Virology 62, 1-7.
19. RAUX, H., COULON, P., LAFAY, F. & FLAMAND, A. (1995). Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Virology 210, 400-408.
20. RINI, J. M., STANFIELD, R. L., STURA, E. A., SALINAS, P. A , PROFY, A. T. & WILSON, I. A. (1993). Crystal structure of human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proceedings of the National Academy of Sciences, USA 90, 6325-6329.
21. SANGER, F., NICKLEN, S. & COULSON, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, USA 74, 5463-5467.
22. SEIF, I., COULON, P., ROLLIN, P. E. & FLAMAND, A. (1985). Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. Journal of Virology 53, 926-934.
23. TORMO, J., BLAAS, D., PARRY, N. R., ROWLANDS, D., STUART, D. & FITA, I. (1994). Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. EMBO Journal 13, 2247-2256.
24. VAN DER HEIJDEN, R. W. J., LANGEDIJK, J. P. M., GROEX, J., UYTDEHAAG, F. G. C. M., MELOEN, R. & OSTERHAUS, A. D. M. E. (1993). Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein Journal of General Virology 74, 1539-1545.